Showing results (61-70 of 123) with videos related to
Sort By:
Pageof 13
Journal of Acquired Immune Deficiency Syndromes (1999)|June 29, 2013
Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of tenofovir alafenamide as 10-day monotherapy in HIV-1-positive adultsPeter J Ruane, Edwin DeJesus, Daniel Berger, et al.AIDS (London, England)|June 24, 2003
Determining the antiviral activity of tenofovir disoproxil fumarate in treatment-naive chronically HIV-1-infected individualsMichael Louie, Christine Hogan, Arlene Hurley, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|August 29, 2006
Antiviral activity, pharmacokinetics, and dose response of the HIV-1 integrase inhibitor GS-9137 (JTK-303) in treatment-naive and treatment-experienced patientsEdwin DeJesus, Daniel Berger, Martin Markowitz, et al.The Journal of Infectious Diseases|May 26, 2009
Colonization and subsequent skin and soft tissue infection due to methicillin-resistant Staphylococcus aureus in a cohort of otherwise healthy adults infected with HIV type 1Anita Shet, Barun Mathema, Jose R Mediavilla, et al.Journal of the International AIDS Society|June 19, 2025
Effectiveness of islatravir post-exposure prophylaxis after intravenous challenge with simian immunodeficiency virus in rhesus macaquesMartin Markowitz, Agegnehu Gettie, Leslie St Bernard, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|June 30, 2012
Sustained efficacy and safety of raltegravir after 5 years of combination antiretroviral therapy as initial treatment of HIV-1 infection: final results of a randomized, controlled, phase II study (Protocol 004)Eduardo Gotuzzo, Martin Markowitz, Winai Ratanasuwan, et al.Journal of Virology|September 13, 2003
Human immunodeficiency virus type 1 induces persistent changes in mucosal and blood gammadelta T cells despite suppressive therapyMichael A Poles, Shady Barsoum, Wenjie Yu, et al.The Journal of Infectious Diseases|March 28, 2003
Determining the relative efficacy of highly active antiretroviral therapyMichael Louie, Christine Hogan, Michele Di Mascio, et al.Plos Medicine|December 7, 2006
Lack of mucosal immune reconstitution during prolonged treatment of acute and early HIV-1 infectionSaurabh Mehandru, Michael A Poles, Klara Tenner-Racz, et al.The Journal of Infectious Diseases|August 14, 2016
Chronic Hepatitis C Virus Infection and the Proinflammatory Effects of Injection Drug UseMartin Markowitz, Sherry Deren, Charles Cleland, et al.Pageof 13